CausalSentinel

Protein Dossier — TXNDC12 (Thioredoxin domain-containing protein 12)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Inflammatory bowel disease 0.134 0.0147 9.90e-20 Wald ratio 1 trans 3.07e-31
Crohn’s disease 0.133 0.0178 6.13e-14 Wald ratio 1 trans 9.83e-18
Ulcerative colitis 0.132 0.0184 5.86e-13 Wald ratio 1 trans 2.28e-22
Serum creatinine (eGFRcrea) 0.00548 0.0013 2.51e-05 Wald ratio 1 trans NA
Transferrin Saturation -0.0592 0.0152 1.00e-04 Wald ratio 1 trans NA
Iron -0.0586 0.0151 1.08e-04 Wald ratio 1 trans NA
Primary sclerosing cholangitis 0.163 0.0436 1.86e-04 Wald ratio 1 trans NA
Non-cancer illness code self-reported: hypertension 0.0215 0.00607 3.86e-04 Wald ratio 1 trans NA
Age at menarche -0.0297 0.00884 7.70e-04 Wald ratio 1 trans NA
Anorexia nervosa 0.172 0.0512 7.82e-04 Wald ratio 1 trans NA
Heel bone mineral density (BMD) T-score automated -0.0156 0.00471 9.25e-04 Wald ratio 1 trans NA
Serum cystatin C (eGFRcys) 0.00929 0.00288 0.00126 Wald ratio 1 trans NA
…and 117 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4815_25_3 TXD12 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

2 association rows across 2 traits (0 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Plasma PCSK9 levels 1e-7 rs35120342 1 GCST90085917 no MR -> candidate analysis
General cognitive ability 2e-7 rs12406969 1 GCST006269 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 90 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
protozoa infectious disease 0.389 common-variant locus no MR -> candidate analysis
response to statin 0.033 common-variant locus no MR -> candidate analysis
knee fracture 0.032 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1.2e-07, LOEUF=1.3 — LoF-tolerant
GWAS Catalog 6 unique SNPs / 12 rows
ClinVar 94 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance